PIK3CA and cervical cancer: Previous work from our group identified alterations in expression of genes from the PI3K/AKT pathway that were associated with incomplete metabolic response after chemoradiation in cervical cancer, and preliminary data demonstrated an association between PIK3CA activating mutations and inferior recurrence-free survival outcome after radiation [5, 6].